title: Artificial blood.
abstract: Blood substitutes are under development for transfusion in place of donor blood during emergencies and lengthy surgeries. The first generation of blood substitutes is currently in clinical trials.
authors.affiliation: American Red Cross Biomedical Services, Arlington, VA 22307, USA. squiresj@usa.redcross.org
authors.forename: Jerry E
authors.initials: JE
authors.lastname: Squires
mesh_terms: D000818:Animals; D001782:Blood Donors; D001802:Blood Substitutes / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D017848:Blood-Borne Pathogens; D002417:Cattle; D002986:Clinical Trials as Topic; D004655:Emulsions; D005466:Fluorocarbons / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use; D006454:Hemoglobins / Q000009:adverse effects / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D007668:Kidney / Q000378:metabolism; D010100:Oxygen / Q000378:metabolism; D010108:Oxyhemoglobins / Q000737:chemistry / Q000378:metabolism; D010313:Partial Pressure; D012307:Risk Factors; D065227:Transfusion Reaction
chemical_list: D001802:Blood Substitutes; D004655:Emulsions; D005466:Fluorocarbons; D006454:Hemoglobins; D010108:Oxyhemoglobins; C037158:polyhemoglobin; D010100:Oxygen